Huatai Securities
VC Fund
Nanjing, China
Huatai Securities is a VC fund in Nanjing focused on Software and Health Care. Huatai Securities, a Chinese securities group with brokerage and investment services, has acquired AssetMark, a wealth management technology provider.
- Total investments:
- 31
- Last investment:
- Lead investor:
- 23%
Last updated:
For AI agents: llms.txt
Industries Huatai Securities invests in
Stages Huatai Securities invests in
Countries Huatai Securities invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Wang Huiqing
|
|||
|
Zhou Yi
|
|||
Investment Focus
Industry
- Software 6 (19%)
- Health Care 5 (16%)
- Manufacturing 5 (16%)
- Information Technology 4 (13%)
- Medical 3 (10%)
Stage
- Post-IPO Equity 10 (32%)
- Series B 5 (16%)
- Series C 5 (16%)
- Series A 3 (10%)
- Venture - Series Unknown 3 (10%)
Country
- China 28 (90%)
- Canada 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Wang Huiqing
Executive Director
|
Executive Director | Total investments: 0 | Find email | |
|
Zhou Yi
President, Chairman & Director
|
President, Chairman & Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Trinomab
|
Trinomab is a Healthcare company. | $13.5M / Venture - Series Unknown / Jul 16, 2026 | |
Infrawaves
|
Infrawaves is a next Generation High-Performance Network System. | Series A / Jan 02, 2025 | |
Challenge IM
|
Challenge IM focuses on the development and application of membrane filtration process products in the biopharmaceutical field. | Seed / Oct 10, 2024 | |
HUATAI FUTURES
|
HUATAI FUTURES is a financial services center. The company provides services that include investment consulting, asset management, and risk management. | $235.9M / Venture - Series Unknown / May 26, 2022 | |
AUTHINE
|
AUTHINE is a digital platform service provider company. | $15.8M / Series C / Mar 01, 2022 | |
Bo Shengji
|
Bo Shengji is a biotech company that develops tumor cell immunotherapy technology and products for anti-cancer drugs, kits, etc. | Series B / Jan 10, 2022 | |
|
Pengyun Network
|
Pengyun Network is a high-tech enterprise and dual-soft enterprise focusing on software-defined storage products and solutions. It has independently developed the ZettaStor series of software-defined distributed storage products. It has completely independent intellectual property rights and a number of technical patents. It has leadingtechnological advantages in terms of scalability, availability and reliability, and intelligence. At present, customers have covered operators, government, finance, education, hospitals, radio and television, military industry, manufacturing, scientific research and other social fields. For application scenarios such as private clouds, enterprise-level data centers, and large-scale data, help customers effectively optimize IT Infrastructure architecture. | Series B / Dec 28, 2021 | |
Rongzhi Information
|
Rongzhi Information is a robotic process automation software developer focusing on the application of AI technology in the enterprise. | Venture - Series Unknown / Dec 09, 2021 | |
Jyss Bio
|
Jyss Bio is a developer of disposable bioreactors and peripheral equipment. | Series B / Jul 25, 2021 | |
Hesai Technology
|
Hesai Technology designs a laser radar that facilitates autonomous driving. It uses smart sensing technology to develop laser radar for autonomous cars and natural gas leak detection systems, enabling car companies to monitor mixed gas composition, control industrial processes, and detect hazardous gas leaks.Hesai Technology was founded in 2014and is headquartered in Shanghai, China. | $300M / Series D / Jun 08, 2021 | |
| See all 31 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Huatai Securities invest in?
Huatai Securities invests primarily in Software, Health Care and Manufacturing startups, most often at Post-IPO Equity and Series B stage. Most of the 31 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Huatai Securities?
Public channels for Huatai Securities include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Huatai Securities?
The team at Huatai Securities includes Wang Huiqing (Executive Director) and Zhou Yi (President, Chairman & Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
